The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q1 2018 call → NOWe need to determine if management conveys that the reported results do not represent the business as it is actually running today, i.e., that the reported period is stale relative to the operating present. Look for management's own words indicating a gap where current business is ahead of the reported period, grounded in concrete activities, not just plans. Key points from the call: - Larry Merlo discusses the Aetna acquisition, integration planning, and synergies. He mentions that they are making progress on integration, but the transaction hasn't closed. He talks about future programs and populations they will focus on, but these are plans, not yet realized. - Dave Denton discusses Q1 results, guidance, and some initiatives like the eligibility improvement that reduced rejections. He mentions that they are making progress on streamlining, but the reported results are in line with expectations. - The company raised revenue guidance for Retail/Long-Term Care due to stronger prescription growth, but operating profit guidance unchanged due to LTC headwinds. - There is mention of investments in Anthem implementation, which will ramp up later in the year, but that's future. - The call seems like a standard results and outlook discussion. The reported period is Q1 2018, and they discuss guidance for the rest of the year. They don't indicate that the business has fundamentally changed since the period ended. The Aetna deal is pending, but not closed, so it's not part of the current business. The integration planning is ongoing, but that's future. Management does not say that the reported numbers are stale relative to what's happening now. They talk about initiatives that are underway, but these are part of the normal course. The only thing that might be considered is the eligibility improvement, but that's a routine efficiency. The Aetna acquisition is a major future event, but it's not yet part of the business. They are not saying that the current business is ahead of the print; they are just providing guidance. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.